The ILAE/IBE/WHO Global Campaign against Epilepsy: Bringing Epilepsy "Out of the Shadows"
- PMID: 12609455
- DOI: 10.1006/ebeh.2000.0104
The ILAE/IBE/WHO Global Campaign against Epilepsy: Bringing Epilepsy "Out of the Shadows"
Abstract
Epilepsy affects at least 100 million people worldwide at some time in their lives, especially in childhood and adolescence. It is a universal problem involving all ages, races, social classes, and nations. Nevertheless, it has been misunderstood, feared, and stigmatized for more than 3000 years. The psychosocial and economic consequences of epilepsy are considerable in developed nations but are even greater in developing nations, where the treatment gap may vary from 60 to 98%. To address the long-standing worldwide neglect of this disease, a campaign titled Epilepsy: Out of the Shadows has been launched by an alliance of three global organizations: the International League against Epilepsy (ILAE), the International Bureau for Epilepsy (IBE), and the World Health Organization (WHO). Global, regional, and national initiatives are currently underway.
Similar articles
-
Epilepsy Care in the World: results of an ILAE/IBE/WHO Global Campaign Against Epilepsy survey.Epilepsia. 2006 Jul;47(7):1225-31. doi: 10.1111/j.1528-1167.2006.00595.x. Epilepsia. 2006. PMID: 16886987
-
ILAE/IBE/WHO Global Campaign Against Epilepsy: a partnership that works.Curr Opin Neurol. 2013 Apr;26(2):219-25. doi: 10.1097/WCO.0b013e32835f2037. Curr Opin Neurol. 2013. PMID: 23449175 Review.
-
The origins and early development of the ILAE/IBE/WHO global campaign against epilepsy: Out of the shadows.Epilepsia Open. 2024 Feb;9(1):77-83. doi: 10.1002/epi4.12850. Epub 2023 Nov 2. Epilepsia Open. 2024. PMID: 37867422 Free PMC article.
-
The treatment of epilepsy in developing countries: where do we go from here?Bull World Health Organ. 2001;79(4):344-51. Epub 2003 Jul 2. Bull World Health Organ. 2001. PMID: 11357214 Free PMC article.
-
From global campaign to global commitment: The World Health Assembly's Resolution on epilepsy.Epilepsia. 2015 Nov;56(11):1651-7. doi: 10.1111/epi.13192. Epub 2015 Sep 22. Epilepsia. 2015. PMID: 26391429 Review.
Cited by
-
Stigma in epilepsy.Curr Neurol Neurosci Rep. 2014 May;14(5):444. doi: 10.1007/s11910-014-0444-x. Curr Neurol Neurosci Rep. 2014. PMID: 24652452 Review.
-
Underutilization of advanced presurgical studies and high rates of vagus nerve stimulation for drug-resistant epilepsy: a single-center experience and recommendations.Acta Neurochir (Wien). 2022 Feb;164(2):565-573. doi: 10.1007/s00701-021-05055-z. Epub 2021 Nov 13. Acta Neurochir (Wien). 2022. PMID: 34773497
-
Seizure Onset Zone Lateralization Using a Non-linear Analysis of Micro vs. Macro Electroencephalographic Recordings During Seizure-Free Stages of the Sleep-Wake Cycle From Epilepsy Patients.Front Neurol. 2020 Sep 17;11:553885. doi: 10.3389/fneur.2020.553885. eCollection 2020. Front Neurol. 2020. PMID: 33041993 Free PMC article.
-
Modified Atkins Diet in Adolescents and Adults with Drug Resistant Epilepsy: A Systematic Review and Meta-Analysis.J Epilepsy Res. 2024 Jun 30;14(1):1-8. doi: 10.14581/jer.24001. eCollection 2024 Jun. J Epilepsy Res. 2024. PMID: 38978527 Free PMC article. Review.
-
Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling.Nat Neurosci. 2022 Jul;25(7):956-966. doi: 10.1038/s41593-022-01095-5. Epub 2022 Jun 23. Nat Neurosci. 2022. PMID: 35739273 Free PMC article.
LinkOut - more resources
Full Text Sources
Miscellaneous